在乌干达高风险人群中评估疫苗或治疗效果的反事实小组
Andrew Abaasa1,2, Yunia Mayanja1, Zacchaeus Anywaine1
1MRC/UVRI & LSHTM Uganda Research Unit, Entebbe P.O. Box 49, Uganda.
Vaccines
|August 28, 2025
概括
倾向性得分匹配 (PSM) 可以为艾滋病毒预防试验创建反事实组. 以往临床试验的安慰剂组和并发观察数据 (SiVET) 提供了评估治疗疗效的最佳反事实.
科学领域:
- 流行病学
- 临床试验
- 生物统计学
背景情况:
- 评估艾滋病毒预防试验的有效性是积极对照的挑战.
- 调查反事实组对于强有力的治疗效应评估至关重要.
研究的目的:
- 评估倾向性得分匹配 (PSM) 在创建反事实组中的有用性.
- 为了比较模拟HIV疫苗疗效试验 (SiVET) 和其他数据来源之间的HIV发病率.
主要方法:
- 使用了先前艾滋病毒预防试验和观察队列的安慰剂组的数据.
- 使用PSM根据基线特征匹配参与者.
- 在PSM前后的HIV发病率比率 (IRR) 的比较.
主要成果:
- 在PSM之后,参与者的特征在不同组之间是可比的.
- SiVET中的HIV发病率与之前的安慰剂组 (IRR=1. 01) 和并发观察数据 (IRR=0. 74) 相似.
- 与SiVET前的观察数据相比,SiVET中的HIV发病率明显较低 (IRR=0. 48).
结论:
- 实际上,PSM从不同的数据源中创建了可比的反事实组.
- 之前的试验安慰剂组和并发观察数据是最佳的反事实.
- 即使在PSM后,试验前的观察数据也可能高估治疗效果.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Study Designs in Epidemiology
410
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
410
What is an Experiment?
13.2K
An experiment is a planned activity carried out under controlled conditions. The purpose of an experiment is to investigate the relationship between two variables. When one variable causes change in another, we call the first variable the explanatory or independent variable. The affected variable is called the response or dependent variable. In a randomized experiment, the researcher manipulates values of the explanatory variable and measures the resulting changes in the response variable. The...
13.2K
Comparing the Survival Analysis of Two or More Groups
280
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
280
Bias in Epidemiological Studies
671
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
671
Hazard Ratio
241
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
241


